After more than 20 years of guiding global medical technology giant BD (Becton, Dickinson and Company) through transformative periods of growth, Dr. Michael (Mike) Garrison has announced his intent to retire, effective Oct. 2.
Garrison currently serves as executive vice president and president of the Franklin Lakes-based company’s Medical Essentials and BioPharma Systems segments. Over his two-decade tenure, he has held several pivotal leadership roles, including worldwide president of Medication Management Solutions, worldwide president of Surgery, and executive vice president and president of the broader Medical segment. Prior to joining BD in 2005, Garrison built his career across R&D and marketing within the MedTech sector.
As Garrison stays on through the end of the fiscal year, BD has already launched a comprehensive search to identify his successor as president of Medical Essentials.
Meanwhile, the company is adjusting its operational model to support future growth. Moving forward, the BioPharma Systems segment will report directly to Chairman, CEO, and President Tom Polen, highlighting the division’s strategic importance as a core growth driver for the enterprise.
“Mike has made a significant impact on BD over the past two decades, helping guide our company through periods of transformation while always keeping our customers, patients and associates at the center of his decisions,” Polen said. “He has built strong teams, developed exceptional leaders and helped position our business for the future. We are grateful for Mike’s leadership, partnership and many contributions to BD, and we wish him well in his retirement.”
Reflecting on his departure, Garrison emphasized the deep sense of purpose that defined his time with the organization.
“It has been a privilege to spend more than two decades at BD, working alongside talented teams who are deeply committed to improving healthcare around the world,” he said. “I will always value the people, purpose and impact that have made my time at BD so meaningful, and I look forward to seeing the company continue to advance the future of care.”
As one of the world’s largest pure-play medical technology companies, BD operates globally with more than 60,000 employees, delivering billions of healthcare products annually that enhance patient outcomes and clinical efficiency.
